Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-08
DOI
10.1002/alz.12447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Resurrecting the Mysteries of Big Tau
- (2020) Itzhak Fischer et al. TRENDS IN NEUROSCIENCES
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study
- (2020) Yakeel T Quiroz et al. LANCET NEUROLOGY
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
- (2020) Inge M. W. Verberk et al. Alzheimers Research & Therapy
- Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
- (2020) Alexis Moscoso et al. BRAIN
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease
- (2019) Fanny M. Elahi et al. Alzheimers & Dementia
- Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants
- (2018) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
- (2017) K Goozee et al. MOLECULAR PSYCHIATRY
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
- (2017) Kathryn Goozee et al. Scientific Reports
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Comparison of MR-less PiB SUVR quantification methods
- (2015) Pierrick Bourgeat et al. NEUROBIOLOGY OF AGING
- Astrogliosis as a therapeutic target for neurodegenerative diseases
- (2014) Anna Maria Colangelo et al. NEUROSCIENCE LETTERS
- MR-Less Surface-Based Amyloid Assessment Based on 11C PiB PET
- (2014) Luping Zhou et al. PLoS One
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG
- (2012) S. F. Carter et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample
- (2011) H. C. Rossetti et al. NEUROLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started